CMA
PFE icon

Cedar Mountain Advisors’s Pfizer PFE Stock Holding History

Cedar Mountain Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.7K Buy
1,691
+60
+4% +$1.57K 0.01% 208
2026
Q1 		$45.8K Buy
1,631
+682
+72% +$18.2K 0.01% 164
2025
Q4 		$23.6K Buy
949
+12
+1% +$303 ﹤0.01% 169
2025
Q3 		$23.9K Buy
937
+26
+3% +$642 ﹤0.01% 171
2025
Q2 		$22.1K Buy
911
+12
+1% +$280 ﹤0.01% 154
2025
Q1 		$22.8K Buy
899
+12
+1% +$314 0.01% 145
2024
Q4 		$23.5K Buy
887
+24
+3% +$651 0.01% 144
2024
Q3 		$25K Buy
863
+10
+1% +$292 0.01% 136
2024
Q2 		$23.9K Buy
853
+11
+1% +$303 0.01% 125
2024
Q1 		$23.4K Buy
842
+11
+1% +$305 0.01% 126
2023
Q4 		$23.9K Buy
831
+9
+1% +$272 0.01% 118
2023
Q3 		$27.3K Buy
822
+8
+1% +$283 0.01% 95
2023
Q2 		$29.9K Buy
814
+7
+0.9% +$272 0.01% 98
2023
Q1 		$32.9K Buy
807
+6
+0.7% +$259 0.01% 91
2022
Q4 		$41K Buy
801
+5
+0.6% +$240 0.01% 82
2022
Q3 		$35K Buy
796
+6
+0.8% +$292 0.01% 83
2022
Q2 		$41K Buy
790
+5
+0.6% +$255 0.01% 81
2022
Q1 		$41K Buy
785
+5
+0.6% +$259 0.01% 88
2021
Q4 		$46K Buy
780
+5
+0.6% +$248 0.01% 77
2021
Q3 		$33K Sell
775
-67
-8% -$2.97K 0.01% 91
2021
Q2 		$33K Hold
842
– – 0.01% 93
2021
Q1 		$31K Hold
842
– – 0.01% 97
2020
Q4 		$31K Buy
842
+271
+47% +$9.94K 0.01% 99
2020
Q3 		$20K Hold
571
– – 0.01% 106
2020
Q2 		$18K Hold
571
– – 0.01% 110
2020
Q1 		$18K Hold
571
– – 0.01% 93
2019
Q4 		$21K Buy
+571
New +$20.3K 0.01% 106

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Cedar Mountain Advisors's PFE Position: Q2 2026 in Review

Cedar Mountain Advisors increased its Pfizer (PFE) stake by 3.7% in Q2 2026, buying an estimated $1.57K and bringing the position to 1,691 shares worth $40.7K. The position accounts for 0.01% of the portfolio, ranked #208.

Cedar Mountain Advisors first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $46K in Q4 2021. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Cedar Mountain Advisors held 1,691 shares of Pfizer worth $40.7K as of Q2 2026.
  • Cedar Mountain Advisors bought 60 Pfizer shares in Q2 2026, an estimated $1.57K.
  • Pfizer made up 0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #208 holding.
  • Cedar Mountain Advisors first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Cedar Mountain Advisors's Pfizer position peaked at $46K in Q4 2021.
  • 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.